Fiasp (Insulin Aspart) Will Be Another Mealtime Insulin Alternative

Reps will promote Fiasp (FEE-asp, insulin aspart) as an "ultrafast-acting" mealtime insulin for adults.

Think of Fiasp as similar to NovoLog. They're both insulin aspart from the same company...except Fiasp has an additive to speed absorption.

Fiasp starts working about 5 minutes faster than NovoLog.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote